NCA-positive IgA nephropathy presented as alveolar hemorrhage in a COVID-19 patient

被引:4
作者
Apaydin, Hakan [1 ]
Guven, Serdar Can [1 ]
Dogan, Ismail [1 ]
Colak, Aysel [2 ]
Erten, Sukran [1 ]
机构
[1] Ankara City Hosp, Dept Rheumatol, Ankara, Turkey
[2] Ankara City Hosp, Dept Pathol, Ankara, Turkey
来源
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE | 2021年 / 12卷
关键词
Alveolar hemorrhage; ANCA; COVID-19; IgA nephropathy; Intravenous immunoglobulin; Plasmapheresis;
D O I
10.4328/ACAM.20424
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The SARS-CoV-2 virus primarily targets the respiratory system, but extrapulmonary involvements can be frequently seen. We presented a COVID-19 case with anti-neutrophil cytoplasmic antibody-positive IgA nephropathy, alveolar hemorrhage, and rapidly progressive kidney disease. The patient received pulse corticosterolds, plasma exchange, and intravenous immunoglobulin as treatment Azathioprine was added as an immunosuppressive therapy. To the best of our knowledge, this is the first reported case of IgA nephropathy coexisting with COVID-19 infection.
引用
收藏
页码:236 / 240
页数:5
相关论文
共 8 条
[1]   Is Presence of ANCA in Crescentic IgA Nephropathy a Coincidence or Novel Clinical Entity? A Case Series [J].
Bantis, Christos ;
Stangou, Maria ;
Schlaugat, Christoph ;
Alexopoulos, Efstathios ;
Pantzaki, Aphroditi ;
Memmos, Dimitrios ;
Ivens, Katrin ;
Heering, Peter J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (02) :259-268
[2]   High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 [J].
Cao, Wei ;
Liu, Xiaosheng ;
Bai, Tao ;
Fan, Hongwei ;
Hong, Ke ;
Song, Hui ;
Han, Yang ;
Lin, Ling ;
Ruan, Lianguo ;
Li, Taisheng .
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03) :1-6
[3]  
Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
[4]   Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity [J].
Jayne, DRW ;
Chapel, H ;
Adu, D ;
Misbah, S ;
O'Donoghue, D ;
Scott, D ;
Lockwood, CM .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (07) :433-439
[5]   Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis [J].
Klemmer, PJ ;
Chalermskulrat, W ;
Reif, MS ;
Hogan, SL ;
Henke, DC ;
Falk, RJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1149-1153
[6]   Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019 [J].
Loeffler, Christian ;
Mahrhold, Juliane ;
Fogarassy, Peter ;
Beyer, Martin ;
Hellmich, Bernhard .
CHEST, 2020, 158 (05) :E215-E219
[7]  
ROSSI F, 1991, CLIN EXP IMMUNOL, V83, P298
[8]   Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study [J].
Yang, Ya-zi ;
Shi, Su-Fang ;
Chen, Yu-Qing ;
Chen, Min ;
Yang, Yi-He ;
Xie, Xin-Fang ;
Zou, Rong ;
Lv, Ji-Cheng ;
Liu, Li-Jun ;
Zhang, Hong .
CLINICAL KIDNEY JOURNAL, 2015, 8 (05) :482-488